ArticleSurgical endoscopy2025
Short- and long-term outcomes of laparoscopic endoscopic cooperative surgery for duodenal neoplasms: a retrospective single-center study.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-ampullary duodenal tumors are relatively rare; however, advancements in esophagogastroduodenoscopy have improved their detection. Endoscopic resection is effective for treating adenomas and early-stage cancers without lymph node involvement. However, challenges include assessing tumor invasion depth, achieving complete resection, and managing postoperative complications such as delayed perforation. Consequently, laparoscopic endoscopic cooperative surgery (D-LECS) was introduced, but data on its long-term outcomes remain limited.
methodsThis retrospective study reviewed 18 cases of D-LECS performed between June 2016 and October 2024 at Tonan Hospital. Included patients had non-ampullary duodenal tumors-adenoma, mucosal adenocarcinoma, or neuroendocrine neoplasms-without lymph node involvement. Surgical outcomes, complications, and follow-up data were analyzed.
resultsThe median patient age was 65.5 years, and 14 patients were male. Tumors were located in the first (4 cases), second (11 cases), and third (3 cases) portions of the duodenum. The median operative time was 233 min, longer in the reinforcement after endoscopic submucosal dissection group than in the full-thickness resection group (289 vs. 221 min, P = 0.37). A Clavien-Dindo grade ≥ 3a complication occurred only in the first case, involving delayed perforation. The median hospital stay was 12 days. En-bloc and R0 resection rates were 83.3 and 92.9%, respectively. No long-term complications, including stricture or recurrence, were observed over a median follow-up of 37 months.
conclusionsD-LECS demonstrated favorable short- and long-term outcomes for non-ampullary duodenal tumors, with high en-bloc and R0 resection rates. These findings suggest that D-LECS is a viable treatment option for selected duodenal tumors.
Indexed as
Identifiers
40841592What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.